# Jens Hillengaß

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jens-hillenga/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,078 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 59 |
| i10-index | 167 |
| Last Known Institution | Roswell Park Comprehensive Cancer Center |
| OpenAlex ID | https://openalex.org/A5068472643 |
| ORCID iD | https://orcid.org/0000-0002-1778-0010 |
| Works | 368 |

## Researcher papers

- [International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma](https://scholariq.org/papers/international-myeloma-working-group-consensus-criteria-for-response-and-minimal/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Hematological disorders and diagnostics](https://scholariq.org/topics/hematological-disorders-and-diagnostics/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)

## Researcher university

- [Roswell Park Comprehensive Cancer Center](https://scholariq.org/institutions/roswell-park-comprehensive-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.